BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2024 8:00:24 AM | Browse: 213 | Download: 923
Publication Name World Journal of Gastroenterology
Manuscript ID 96272
Country Italy
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
Manuscript Source Invited Manuscript
All Author List Marco Biolato and Maurizio Pompili
ORCID
Author(s) ORCID Number
Marco Biolato http://orcid.org/0000-0002-5172-8208
Maurizio Pompili http://orcid.org/0000-0001-6699-7980
Funding Agency and Grant Number
Corresponding Author Marco Biolato, MD, PhD, Staff Physician, Department of Medical and Surgical Sciences, CEMAD Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli 8, 00168, Rome 00168, Italy. marco.biolato@policlinicogemelli.it
Key Words Chemotherapeutic drugs; Lipiodol; Post-embolization syndrome; Prevention; Prophylaxis
Core Tip Post-embolization syndrome is the most common complication of transarterial chemoembolization, which represents the most widespread treatment of hepatocellular carcinoma. In a single-center, placebo-controlled trial, Simasingha et al documented the efficacy and safety of the prophylactic administration of dexamethasone and N-Acetylcysteine in the prevention of post-embolization syndrome in these patients. The applicability of this prophylaxis in the Western world presents some concerns. In the West, there are important differences in the disease etiology, the drug used, and the use of microspheres, compared to the Eastern scenario. Furthermore, the use of dexamethasone presents risks that must be carefully evaluated in this population.
Publish Date 2024-08-13 08:00
Citation

Biolato M, Pompili M. Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective. World J Gastroenterol 2024; 30(31): 3635-3639

URL https://www.wjgnet.com/1007-9327/full/v30/i31/3635.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i31.3635
Full Article (PDF) WJG-30-3635-with-cover.pdf